NMI TT Pharmaservices opens new branch in Berlin, Germany

The new outstation is located on the Bayer HealthCare campus, within the CoLaborator building that is rented out by Bayer to smaller companies and start-ups.

NMI TT Pharmaservices will be using the new and already functional laboratory space to provide life science researchers with its proprietary DigiWest multiplex protein profiling services, to accelerate lead characterisation, disease mechanism and drug mode-of-action analyses as well as biomarker identification projects for industrial clients and academic partners alike.

In addition, the new office will play a key role for advancing NMI TT Pharmaservices’ market positioning by expanding its business activities beyond the existing well-established customer base.

NMI TT CEO Hugo Hämmerle said: "We are very excited to start this new phase in our company’s development.

"We see our expansion to Berlin as a unique opportunity to intensify our business development efforts across the international pharma and biotech market. This move also happens at a particularly promising time in the development of the proteomics field, which we are keen to help drive forward in the years to come, now through both our Reutlingen team and our new Berlin unit.

NMI TT Berlin operation site head Christoph Sachse said: "The chances of this new endeavour are manifold.

"We expect that being closer to the needs of pharma R&D scientists and the lively Berlin biotech community will substantially help us in further developing and in marketing our wide range of contract research offerings, in particular our multiplex protein profiling platform, but also our capabilities in cellular assays and in generating customised cell lines."